Evidence map›Paper›PMID 34173857›Full record

ArticleArchives of toxicology2021

Activation of (un)regulated cell death as a new perspective for bispyridinium and imidazolium oximes.

Antonio Zandona, Nikola Maraković, Petra Mišetić, Josip Madunić, Katarina Miš, Jasna Padovan, Sergej Pirkmajer, Maja Katalinić

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Effects ofArhiv za higijenu rada i toksikologiju · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Potential of Vitamin B6 Dioxime Analogues to Act as Cholinesterase Ligands.International journal of molecular sciences · 2022
    Article
  10. Article
  11. Recent research on Novichok.Archives of toxicology · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Antonio ZandonaInstitute for Medical Research and Occupational Health, POB 291, 10001, Zagreb, Croatia.
Nikola MarakovićInstitute for Medical Research and Occupational Health, POB 291, 10001, Zagreb, Croatia.
Petra MišetićFidelta Ltd., 10001, Zagreb, Croatia.
Josip MadunićInstitute for Medical Research and Occupational Health, POB 291, 10001, Zagreb, Croatia.
Katarina MišFaculty of Medicine, Institute of Pathophysiology, University of Ljubljana, Ljubljana, Slovenia.
Jasna PadovanFidelta Ltd., 10001, Zagreb, Croatia.
Sergej PirkmajerFaculty of Medicine, Institute of Pathophysiology, University of Ljubljana, Ljubljana, Slovenia.
Maja KatalinićInstitute for Medical Research and Occupational Health, POB 291, 10001, Zagreb, Croatia. mkatalinic@imi.hr.ORCID http://orcid.org/0000-0001-7043-4291
Institute for Medical Research and Occupational Health · HRPliva (Croatia) · HRUniversity of Ljubljana · SI

Funding

Hrvatska Zaklada za Znanost HrZZ-UIP-2017-05-7260Javna Agencija za Raziskovalno Dejavnost RS J7-8276Javna Agencija za Raziskovalno Dejavnost RS P3-0043Ministry of Science and Technology, Croatia Croatian-Slovenian Bilateral grant 2020-2021
6 · The paper itself

Abstract

Oximes, investigated as antidotes against organophosphates (OP) poisoning, are known to display toxic effects on a cellular level, which could be explained beyond action on acetylcholinesterase as their main target. To investigate this further, we performed an in vitro cell-based evaluation of effects of two structurally diverse oxime groups at concentrations of up to 800 μM, on several cell models: skeletal muscle, kidney, liver, and neural cells. As indicated by our results, compounds with an imidazolium core induced necrosis, unregulated cell death characterized by a cell burst, increased formation of reactive oxygen species, and activation of antioxidant scavenging. On the other hand, oximes with a pyridinium core activated apoptosis through specific caspases 3, 8, and/or 9. Interestingly, some of the compounds exhibited a synergistic effect. Moreover, we generated a pharmacophore model for each oxime series and identified ligands from public databases that map to generated pharmacophores. Several interesting hits were obtained including chemotherapeutics and specific inhibitors. We were able to define the possible structural features of tested oximes triggering toxic effects: chlorine atoms in combination with but-2(E)-en-1,4-diyl linker and adding a second benzene ring with substituents such as chlorine and/or methyl on the imidazolium core. Such oximes could not be used in further OP antidote development research, but could be introduced in other research studies on new specific targets. This could undoubtedly result in an overall improved wider use of unexplored oxime database created so far in OP antidotes field of research in a completely new perspective.

Indexed as

AnimalsAntidotesAntioxidantsApoptosisCell LineCell Line, TumorDogsDrug SynergismHumansMadin Darby Canine Kidney CellsOximesPyridinium CompoundsReactive Oxygen SpeciesRegulated Cell DeathStructure-Activity RelationshipAntidotesAntioxidantsOximesPyridinium CompoundsReactive Oxygen SpeciesApoptosisCaspaseCytotoxicityOximesPermeabilityPharmacophore

Identifiers

PMID34173857
OpenAlexW3175899028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.